Free Trial

Ascendis Pharma A/S (ASND) SEC Filings & 10K Form

Ascendis Pharma A/S logo
$174.96 -1.53 (-0.87%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$174.94 -0.02 (-0.01%)
As of 07/11/2025 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Ascendis Pharma A/S SEC Filings

DateFilerForm TypeView
06/02/2025
7:06 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
3:03 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2025
10:59 AM
Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
9:47 AM
Ascendis Pharma A/S (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G
05/12/2025
11:13 AM
Ascendis Pharma A/S (Subject)
Shu Aimee (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:18 AM
Ascendis Pharma A/S (Subject)
Shu Aimee (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
3:14 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
3:15 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2025
3:01 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2025
3:01 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2025
3:17 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2025
3:48 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
4:03 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:51 PM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
1:31 PM
Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:38 PM
Ascendis Pharma A/S (Subject)
Hartvig Camilla Harder (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:27 PM
Ascendis Pharma A/S (Subject)
Fairey William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:32 PM
Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:15 PM
Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:22 PM
Ascendis Pharma A/S (Subject)
IMANI SIHAM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:50 PM
Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:55 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:00 PM
Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:04 PM
Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:09 PM
Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:12 PM
Ascendis Pharma A/S (Subject)
HOLTUG LARS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:40 PM
Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:45 PM
Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:02 PM
Ascendis Pharma A/S (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/21/2025
5:11 AM
Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
4:06 PM
Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:56 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
10:54 AM
Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/12/2025
3:15 PM
Ascendis Pharma A/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/12/2025
2:24 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/11/2025
8:15 AM
Ascendis Pharma A/S (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SCHEDULE 13G/A
01/15/2025
3:39 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2025
5:03 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2025
5:05 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
3:04 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
5:04 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
"I'm risking my reputation on this" (Ad)

Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.

Claim your FREE copy of Crypto Revolution now.
12/10/2024
4:02 PM
Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
4:07 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
4:16 PM
Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:44 PM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
3:35 PM
Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:46 PM
Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
1:57 PM
Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
8:31 AM
Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
11/13/2024
3:02 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2024
8:51 AM
Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
Form SC 13G/A
11/08/2024
9:34 AM
Ascendis Pharma A/S (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/04/2024
6:05 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
7:35 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:59 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
4:20 PM
Ascendis Pharma A/S (Filer)
Form 424B5
09/18/2024
3:01 PM
Ascendis Pharma A/S (Filer)
Form F-3ASR
09/16/2024
6:28 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
6:32 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
3:01 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:10 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:11 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
4:14 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2024
6:05 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ASND) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners